NCT04040738

Brief Summary

The application of RA can decrease the central sensitization and chronic pain after trauma surgery. The plasma concentrations of somatostatin and fatty acid amides were not studied up to this time in this kind of settings, so investigators believe that this is the first work that shows how upper extremity nerve blockade changes the plasma concentration of somatostatin and fatty acid amides in upper limb surgery in trauma patients.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P75+ for not_applicable postoperative-pain

Timeline
Completed

Started Nov 2019

Longer than P75 for not_applicable postoperative-pain

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 5, 2019

Completed
2 months until next milestone

First Posted

Study publicly available on registry

August 1, 2019

Completed
3 months until next milestone

Study Start

First participant enrolled

November 5, 2019

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 20, 2021

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 10, 2022

Completed
Last Updated

November 5, 2021

Status Verified

November 1, 2021

Enrollment Period

2 years

First QC Date

June 5, 2019

Last Update Submit

November 4, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Somatostatin concentration in plasma

    Plasma concentrations of somatostatin straight after and 6 hours after surgery.

    0-6 hours after surgery

Secondary Outcomes (2)

  • Endocannabinoid concentrations in plasma

    0-6 hours

  • Corticosteroid concentrations in plasma

    0-6 hours

Other Outcomes (1)

  • Postoperative pain intensity: verbal numeric rate scale

    0-24 hours

Study Arms (2)

Upper extremity surgery under general anaesthesia

ACTIVE COMPARATOR

Fentanyl 2 mcg/kg iv, propofol 2 mg/kg iv induction, 1MAC sevoflurane maintenance

Procedure: Upper extremity surgery under general anaesthesia

Upper extremity surgery under regional anaesthesia

ACTIVE COMPARATOR

Bupivacaine brachial plexus block 0.4 ml/kg of 0.33% solution

Procedure: Upper extremity surgery under regional anaesthesia

Interventions

Forearm, wrist and hand surgery after fentanyl and propofol induction of anaesthesia, with sevoflurane maintenance

Upper extremity surgery under general anaesthesia

Forearm, wrist and hand surgery under brachial plexus block with 0.4 ml/kg of 0.33% bupivacaine solution Other Names: Marcaine 5 mg/ml Astra Zeneca OGYI-T 6496/14

Upper extremity surgery under regional anaesthesia

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • upper extremity fracture
  • surgery of hand/forearm or upper arm
  • unpremedicated patients
  • scheduled for elective or emergency trauma

You may not qualify if:

  • psycho-mental conditions interfering with consent or assessment
  • the patient refused to participate
  • preexisting chronic pain condition
  • daily analgesic or sedative or steroid consumption
  • sedative or analgesic premedication
  • pre-existing neuro-endocrine disorders
  • antecedent cancer
  • advanced liver or kidney disease.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Pécs, Medical School

Pécs, Baranya, 7632, Hungary

RECRUITING

MeSH Terms

Conditions

Pain, PostoperativeArm Injuries

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and SymptomsWounds and Injuries

Study Officials

  • Robert G Almasi, PhD.Habil.

    University of Pecs, Medical School, Clinical Centre, Pain Medicine Dept.of Anesth Int Care

    STUDY CHAIR
  • Zsofia Kriszta, MD.

    University of Pecs, Medical School, Clinical Centre, Dept.of Anesth Int Care

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Robert G Almasi, PhD.Habil.

CONTACT

Erika Pintér, DSC., Prof

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
The labour analyst, the investigator, the statistician is unaware of group allocation.
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Model Details: Study participants n=25 in the S-GA, n=25 in the S-RA, n=25 in the H-GA, and n=25 in the H-RA Groups.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 5, 2019

First Posted

August 1, 2019

Study Start

November 5, 2019

Primary Completion

November 20, 2021

Study Completion

January 10, 2022

Last Updated

November 5, 2021

Record last verified: 2021-11

Data Sharing

IPD Sharing
Will not share

Locations